How do you feel? study asks patients with rare blood conditions

NCT ID NCT05136807

Recruiting now Knowledge-focused Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 29 times

Summary

This study looks at the quality of life of people with two early blood conditions: monoclonal gammopathy of unknown significance (MGUS) and smoldering multiple myeloma. Researchers want to learn about the most common symptoms and concerns these patients face. Participants will fill out short questionnaires about their well-being at the start and then every 6 months (or monthly if in a treatment study) for up to 3 years. The goal is to gather information, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

M D Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE SMOLDERING PLASMA CELL MYELOMA